BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 33198260)

  • 1. Pharmacogenomics for Primary Care: An Overview.
    Rollinson V; Turner R; Pirmohamed M
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
    Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR
    Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
    Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
    J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners.
    van der Drift D; Simoons M; Koch BCP; Brufau G; Bindels P; Matic M; van Schaik RHN
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics - a minor rather than major force in clinical medicine.
    Polasek TM
    Expert Rev Clin Pharmacol; 2024 Mar; 17(3):203-212. PubMed ID: 38307498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.
    Vest BM; Wray LO; Brady LA; Thase ME; Beehler GP; Chapman SR; Hull LE; Oslin DW
    BMC Psychiatry; 2020 Oct; 20(1):518. PubMed ID: 33115428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Pain Management with Pharmacogenomics: A General Introduction.
    Schuh MJ; Randles H; Crosby S
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):114-119. PubMed ID: 32186418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
    Zhu Y; Swanson KM; Rojas RL; Wang Z; St Sauver JL; Visscher SL; Prokop LJ; Bielinski SJ; Wang L; Weinshilboum R; Borah BJ
    Genet Med; 2020 Mar; 22(3):475-486. PubMed ID: 31591509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.
    Saya S; Chondros P; Abela A; Mihalopolous C; Chatterton ML; Gunn J; Chen TF; Polasek TM; Dettmann E; Brooks R; King M; Spencer L; Alphonse P; Milton S; Ramsay G; Siviour Z; Liew J; Ly P; Thoenig M; Seychell R; La Rocca F; Hesson LB; Mejias N; Sivertsen T; Galea MA; Bousman C; Emery J
    Trials; 2023 May; 24(1):342. PubMed ID: 37208772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
    Shahabi P; Dubé MP
    Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 14. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.
    Yamamoto PA; Conchon Costa AC; Lauretti GR; de Moraes NV
    Pharmacogenomics; 2019 Aug; 20(13):971-982. PubMed ID: 31486733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice.
    Russmann S; Rahmany A; Niedrig D; Hatz KD; Ludin K; Burden AM; Englberger L; Backhaus R; Serra A; Béchir M
    Eur J Clin Pharmacol; 2021 May; 77(5):709-716. PubMed ID: 33242107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic testing in paediatrics: Clinical implementation strategies.
    Barker CIS; Groeneweg G; Maitland-van der Zee AH; Rieder MJ; Hawcutt DB; Hubbard TJ; Swen JJ; Carleton BC
    Br J Clin Pharmacol; 2022 Oct; 88(10):4297-4310. PubMed ID: 34907575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
    Socco S; Wake DT; Lee JC; Dunnenberger HM
    Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial.
    Oslin DW; Chapman S; Duvall SL; Gelernter J; Ingram EP; Kranzler HR; Lehmann LS; Lynch JA; Lynch KG; Pyne JM; Shih MC; Stone A; Thase ME; Wray LO
    Contemp Clin Trials; 2021 Feb; 101():106247. PubMed ID: 33316457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
    Shriver SP; Adams D; McKelvey BA; McCune JS; Miles D; Pratt VM; Ashcraft K; McLeod HL; Williams H; Fleury ME
    J Clin Oncol; 2024 Apr; 42(10):1181-1192. PubMed ID: 38386947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.